Lynn Kasper

Lynn Kasper is an accomplished executive with extensive experience in commercial strategy and business development within the biopharmaceutical and healthcare sectors. Currently serving as Vice President of Commercial at Epikast since 2024, Lynn partners with biopharmaceutical companies to enhance stakeholder engagement through personalized communication. Previous roles include Vice President of Strategic Development & Partnerships at Huma.AI, and Vice President of Global Strategy at H1, where Lynn contributed to advancing therapeutic development through innovative data solutions. Lynn also held various leadership positions at Amplity Health, IQVIA, Synovate Healthcare, ImpactRx, Bristol Myers Squibb, and IMS Health, demonstrating a consistent track record of exceeding revenue goals and developing successful market strategies. Lynn holds a Bachelor’s degree in Economics and Finance from Villanova University.